CCL
51
3
CSCO
67
3
MS
69
3
WYNN
28
-2
PH
57
4
AEE
63
5
VLO
33
4
MCO
68
4
VMC
33
3
CFG
60
2
AIZ
52
2
EQIX
59
2
YUM
33
-2
VZ
27
3
RCL
64
3
ADI
62
5
V
50
2
EXR
37
15
PM
56
2
UA
51
-5
CCL
51
3
CSCO
67
3
MS
69
3
WYNN
28
-2
PH
57
4
AEE
63
5
VLO
33
4
MCO
68
4
VMC
33
3
CFG
60
2
AIZ
52
2
EQIX
59
2
YUM
33
-2
VZ
27
3
RCL
64
3
ADI
62
5
V
50
2
EXR
37
15
PM
56
2
UA
51
-5
Financhill
Back

Collegium Pharmaceutical Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Today's Fastest Growing Company Might Surprise You

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Collegium Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Collegium Pharmaceutical has on average historically risen by 8.4% based on the past 9 years of stock performance.
  • Collegium Pharmaceutical has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Collegium Pharmaceutical Stock Undervalued?
    The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Collegium Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Collegium Pharmaceutical has on average historically risen by 8.4% based on the past 9 years of stock performance.

Collegium Pharmaceutical Stock Rating

Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical overpriced?

  • Collegium Pharmaceutical has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Collegium Pharmaceutical Stock Price History

Is COLL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
collegiumpharma.com

52-Week Data

52-Week High:
42.29
52-Week Low:
28.39

Prediction Charts

Market Cap:
1.1B
Price in USD:
33.34
Volume:
1.2M
Beta:
0.81

Technical Analysis

SMA50:
30.91
SMA100:
34.22
SMA200:
34.47
52-Wk Change:
5.04%

Stock Predictions

  • Is Collegium Pharmaceutical stock public?
    Yes, Collegium Pharmaceutical is a publicly traded company.
  • What is the Collegium Pharmaceutical stock quote today?
    The Collegium Pharmaceutical stock price is 33.34 USD today.
  • How to buy Collegium Pharmaceutical stock online?
    You can buy Collegium Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 30.95 30.02 31.14 29.48
Dec-19 30.28 30.44 30.83 29.82
Dec-20 30.39 29.70 31.06 29.53
Dec-23 29.69 29.15 30.20 28.97
Dec-24 29.09 29.06 29.26 28.75
Dec-26 29.13 29.49 29.58 28.86
Dec-27 29.27 29.11 29.49 28.84
Dec-30 28.86 28.61 29.10 28.50
Dec-31 28.70 28.65 29.18 28.47
Jan-2 28.95 28.63 29.28 28.40
Jan-3 28.60 29.51 29.58 28.39
Jan-6 29.51 28.62 29.70 28.55
Jan-7 28.61 29.14 29.88 28.53
Jan-8 29.18 33.34 33.70 29.18

Collegium Pharmaceutical Earnings

Collegium Pharmaceutical Earnings Report: Per Share Collegium Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Collegium Pharmaceutical Forecast Revenue Growth

Collegium Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Collegium Pharmaceutical and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

* Collegium Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.